The study by Georgakopoulou VE et al. confirmed that, regardless of vaccination status, pre-existing comorbidities, age, and gender, patients with a combination of biomarkers indicating acute inflammatory response, cell death, and hypercoagulability—specifically, CRP, LDH, and fibrinogen—reflected the severity of COVID-19 [78]. The gene discussed is CRP; the disease is COVID-19.